Can we target our gut bacteria to make immunotherapies safer?

Targeting the gut microbiota to improve the safety and efficacy of agonistic cancer immunotherapies
People
Project Status: In progress
Project administered by: Flinders University

People

  • Professor Tim Hughes

    Professor Tim Hughes

    Group Leader, CML Group

  • Professor David Lynn

    Professor David Lynn

    Director, Computational & Systems Biology Program

  • Professor Geraint Rogers

    Professor Geraint Rogers

    Director, Microbiome And Host Health Program

  • Associate Professor Marten Snel

    Associate Professor Marten Snel

    Head Proteomics, Metabolomics & MS-Imaging

  • Dr Paul Trim

    Dr Paul Trim

    Manager, Metabolomics and MS-Imaging Core Facility

  • Professor Deborah White

    Professor Deborah White

    Theme Leader

  • Dr Susan Woods

    Dr Susan Woods